文献速递造血干细胞移植与细胞治疗白血病

免疫分析与机器学习揭示PTCy后GVHD与复发的特征

Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning.
PubMed 文献 · Blood · 2022-01-01

该研究对70例接受PTCy方案单倍体移植和75例HLA相合骨髓移植患者的免疫重建动力学进行分析,利用机器学习从35个候选因子中识别预测aGVHD、OS等结局的免疫特征。研究发现第28天效应CD4+Tconv与CXCL9同时升高预测aGVHD,NK细胞计数较高预测OS改善;复发患者NK细胞炎症基因签名丢失、CD8+T细胞呈转录耗竭表型。

要点

  • 第28天效应CD4+Tconv与CXCL9同时升高预测aGVHD。
  • NK细胞计数较高与OS改善相关,源于非复发死亡和复发均减少。
  • 早期复发者NK细胞炎症基因签名丢失、CD8+T细胞转录耗竭。

核心结论

  • 基于PTCy的haplo与HLA相合BMT后,第28天效应CD4+Tconv和CXCL9同时升高预测aGVHD。
  • NK细胞计数较高预测OS改善,与NRM和复发减少均相关。
  • 早期复发者NK细胞炎症基因签名丢失、CD8+T细胞呈转录耗竭表型。

研究设计与样本

  • 研究纳入70例接受PTCy方案haplo BMT和75例HLA相合BMT患者。
  • 采用机器学习分析35个候选因子(10项临床、18项细胞、7项蛋白组学)。
  • 对预测主要移植结局的淋巴细胞亚群进行转录组分析。

主要发现

  • 70例haplo与75例HLA相合BMT患者第28天后免疫亚群重建动力学相似。
  • 第28天效应CD4+Tconv与CXCL9同时升高预测aGVHD。
  • NK细胞计数较高预测OS改善,非复发死亡和复发均减少。
  • aGVHD患者恢复中的淋巴细胞保留功能性CD4+Treg特征,并呈现Tconv驱动的炎症代谢轴。
  • 早期复发患者NK细胞炎症基因签名丢失、CD8+T细胞呈转录耗竭表型。

临床怎么用

  • 可利用第28天效应CD4+Tconv与CXCL9联合升高识别aGVHD高风险患者。
  • NK细胞计数较高提示OS改善,可作为移植后免疫监测参考指标。

局限性

  • 原文未报告具体局限性描述。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The key immunologic signatures associated with clinical outcomes after posttransplant cyclophosphamide (PTCy)-based HLA-haploidentical (haplo) and HLA-matched bone marrow transplantation (BMT) are largely unknown. To address this gap in knowledge, we used machine learning to decipher clinically relevant signatures from immunophenotypic, proteomic, and clinical data and then examined transcriptome changes in the lymphocyte subsets that predicted major posttransplant outcomes. Kinetics of immune subset reconstitution after day 28 were similar for 70 patients undergoing haplo and 75 patients undergoing HLA-matched BMT. Machine learning based on 35 candidate factors (10 clinical, 18 cellular, and 7 proteomic) revealed that combined elevations in effector CD4+ conventional T cells (Tconv) and CXCL9 at day 28 predicted acute graft-versus-host disease (aGVHD). Furthermore, higher NK cell counts predicted improved overall survival (OS) due to a reduction in both nonrelapse mortality and relapse. Transcriptional and flow-cytometric analyses of recovering lymphocytes in patients with aGVHD identified preserved hallmarks of functional CD4+ regulatory T cells (Tregs) while highlighting a Tconv-driven inflammatory and metabolic axis distinct from that seen with conventional GVHD prophylaxis. Patients developing early relapse displayed a loss of inflammatory gene signatures in NK cells and a transcriptional exhaustion phenotype in CD8+ T cells. Using a multimodality approach, we highlight the utility of systems biology in BMT biomarker discovery and offer a novel understanding of how PTCy influences alloimmune responses. Our work charts future directions for novel therapeutic interventions after these increasingly used GVHD prophylaxis platforms. Specimens collected on NCT0079656226 and NCT0080927627 https://clinicaltrials.gov/.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. McCurdy SR, Radojcic V, Tsai HL, et al. Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning. Blood. 2022. PMID: 34657151. doi:10.1182/blood.2021013054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。